Journal
NANO TODAY
Volume 4, Issue 5, Pages 414-428Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.nantod.2009.07.004
Keywords
Quantum dots; Nanoparticles; Molecular profiling; Fluorescence; Multiplexing; Pathology; Diagnosis; Targeted therapy; Drug delivery; Personalized medicine
Categories
Funding
- NCI NIH HHS [R01 CA131797-02, R01 CA131797] Funding Source: Medline
Ask authors/readers for more resources
Successes in biomedical research and state-of-the-art medicine have undoubtedly improved the quality of life. However, a number of diseases, such as cancer, immunodeficiencies, and neurological. disorders, still evade conventional diagnostic and therapeutic approaches. A transformation towards personalized medicine may help to combat these diseases. For this, identification of disease molecular fingerprints and their association with prognosis and targeted therapy must become available. Quantum dots (QDs), semiconductor nanocrystals with unique photo-physical properties, represent a novel class of fluorescence probes to address many of the needs of personalized medicine. This review outlines the properties of QDs that make them a suitable platform for advancing personalized medicine, examines several proof-of-concept studies showing utility of QDs for clinically relevant applications, and discusses current challenges in introducing QDs into clinical practice. (C) 2009 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available